{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:23:37Z","timestamp":1766755417467,"version":"3.48.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-024-01328-8","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T23:59:03Z","timestamp":1734134343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Osteomalacia: A Challenging Diagnosis Adverse Event Associated with Intravenous Ferric Carboxymaltose\u2014A Case Report"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4941-594X","authenticated-orcid":false,"given":"Mauro","family":"Ferre-Sanfrancisco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"del Bosque Granero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Valero","family":"Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica V\u00e1zquez","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"issue":"7","key":"1328_CR1","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1007\/s12325-021-01770-2","volume":"38","author":"JA Glaspy","year":"2021","unstructured":"Glaspy JA, Wolf M, Strauss WE (2021) Intravenous iron-induced hypophosphatemia: an emerging syndrome. Adv Ther 38(7):3531\u20133549. https:\/\/doi.org\/10.1007\/s12325-021-01770-2","journal-title":"Adv Ther"},{"issue":"5","key":"1328_CR2","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1111\/bcp.14643","volume":"87","author":"B Schaefer","year":"2021","unstructured":"Schaefer B, Tobiasch M, Viveiros A, Tilg H, Kennedy NA, Wolf M et al (2021) Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside\u2014a systematic review and meta-analysis. Br J Clin Pharmacol 87(5):2256\u20132273. https:\/\/doi.org\/10.1111\/bcp.14643","journal-title":"Br J Clin Pharmacol"},{"key":"1328_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116202","volume":"154","author":"B Schaefer","year":"2022","unstructured":"Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M et al (2022) Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management. Bone 154:116202. https:\/\/doi.org\/10.1016\/j.bone.2021.116202","journal-title":"Bone"},{"issue":"3","key":"1328_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/bjh.17202","volume":"193","author":"D Rund","year":"2021","unstructured":"Rund D (2021) Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice? Br J Haematol 193(3):466\u2013480. https:\/\/doi.org\/10.1111\/bjh.17202","journal-title":"Br J Haematol"},{"issue":"3","key":"1328_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/1744-9987.13435","volume":"24","author":"G Coppolino","year":"2020","unstructured":"Coppolino G, Nicotera R, Cernaro V, Calimeri S, Leonardi G, Cosentino S et al (2020) Iron infusion and induced hypophosphatemia: the role of fibroblast growth Factor-23. Ther Apher Dial 24(3):258\u2013264. https:\/\/doi.org\/10.1111\/1744-9987.13435","journal-title":"Ther Apher Dial"},{"issue":"3","key":"1328_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tmrv.2020.07.002","volume":"34","author":"I Bellos","year":"2020","unstructured":"Bellos I, Frountzas M, Pergialiotis V (2020) Comparative risk of hypophosphatemia following the administration of intravenous iron formulations: a network meta-analysis. Transfus Med Rev 34(3):188\u2013194. https:\/\/doi.org\/10.1016\/j.tmrv.2020.07.002","journal-title":"Transfus Med Rev"},{"issue":"6","key":"1328_CR7","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/jbmr.4558","volume":"37","author":"T Vilaca","year":"2022","unstructured":"Vilaca T, Velmurugan N, Smith C, Abrahamsen B, Eastell R (2022) Osteomalacia as a complication of intravenous iron infusion: a systematic review of case reports. J Bone Miner Res 37(6):1188\u20131199. https:\/\/doi.org\/10.1002\/jbmr.4558","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01328-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:20:36Z","timestamp":1766755236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01328-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1328"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01328-8","relation":{},"ISSN":["1432-0827"],"issn-type":[{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2024,12,14]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mauro Ferre-Sanfrancisco, Iv\u00e1n del Bosque Granero, Marta Valero Exp\u00f3sito, and M\u00f3nica V\u00e1zquez D\u00edaz declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The patient signed his written informed consent before the report was included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}}],"article-number":"1"}}